11:10 31/08/2016 Changes To Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Target Prices
Changes To Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Target Prices
Fiscal Standard - 5 hours ago
05/13/2015 - Arena Pharmaceuticals, Inc. had its “market perform” rating reiterated by analysts at BMO Capital Markets.

13:11 30/08/2016 Analyst Ratings Worth Mentioning Today: Arena Pharmaceuticals, Inc. (NASDAQ ...
Analyst Ratings Worth Mentioning Today: Arena Pharmaceuticals, Inc. (NASDAQ ...
Review Fortune - Aug 30, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) remained bearish with a decrease -1.84% putting the price on the $1.60 per share in last trading session ended on 8/29/2016.
Revenue Estimates Analysis: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - News Oracle
Analysts watching two Stocks: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) , Jazz ... - Street Updates

9:48 30/08/2016 Key Analyst's EPS Estimates: Abbott Laboratories (NYSE:ABT) , Arena ...
Key Analyst's EPS Estimates: Abbott Laboratories (NYSE:ABT) , Arena ...
Is stories - Aug 30, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) finished the trade at $1.60, lower -1.84%. Its last's traded volume was 1.36 million shares in comparison to its average trading volume of 1.44 million shares.

11:07 29/08/2016 Innovus Pharma (INNV) Adds Former Arena Pharma Exec as CFO
Innovus Pharma (INNV) Adds Former Arena Pharma Exec as CFO
StreetInsider.com - Aug 29, 2016
Innovus Pharmaceuticals, Inc. (OTC: INNV) announced today that Mr. Robert Hoffman will join the management team as Executive Vice President and Chief Financial Officer effective September 6, 2016.
Innovus Pharma appoints Robert Hoffman as EVP and CFO - RTT News

22:30 25/08/2016 Arena Pharmaceuticals Inc. (ARNA) Drops 5.36% on August 24
Arena Pharmaceuticals Inc. (ARNA) Drops 5.36% on August 24
Equities.com - Aug 25, 2016
Arena Pharmaceuticals Inc. (ARNA) was one of the Russell 2000's biggest losers for Wednesday August 24 as the stock slid 5.36% to $1.59, a loss of $-0.09 per share.

16:56 25/08/2016 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock Declines, Analysts: Hold Rating
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock Declines, Analysts: Hold Rating
Review Fortune - Aug 25, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) down -1.85% for the past 5 days, is under coverage of 6 analysts who collectively assign a hold rating on stock.
New Broker Ratings For Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - FTSE News
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s Company Shares Decreased 7.02 ... - Press Telegraph

14:18 11/08/2016 Zacks Investment Research Downgrades Arena Pharmaceuticals Inc. (ARNA) to Sell
Zacks Investment Research Downgrades Arena Pharmaceuticals Inc. (ARNA) to Sell
The Cerbat Gem - Aug 11, 2016
Arena Pharmaceuticals logo Arena Pharmaceuticals Inc. (NASDAQ:ARNA) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Thursday.
JPMorgan Chase & Co. Reaffirms Hold Rating for Arena Pharmaceuticals Inc. (ARNA) - BBNS

20:30 10/08/2016 Needham Remains Sidelined on Arena Pharmaceuticals, Inc. (ARNA) Following ...
Needham Remains Sidelined on Arena Pharmaceuticals, Inc. (ARNA) Following ...
Smarter Analyst - Aug 10, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) released second-quarter results and hosted a quarterly call, where management provided a corporate update as well as an update on clinical progress.

21:35 08/08/2016 Stock Update (NASDAQ:ARNA): Arena Pharmaceuticals, Inc. Reports Second Quarter ...
Stock Update (NASDAQ:ARNA): Arena Pharmaceuticals, Inc. Reports Second Quarter ...
Smarter Analyst - Aug 8, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported financial results for the second quarter ended June 30, 2016, and provided a corporate update.
What to Expect in Arena Pharmaceuticals Earnings (ARNA) - Investopedia
Analyst's Estimates: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Post Registrar

14:23 04/08/2016 Top Biotechnology Stock Picking: INSYS Therapeutics, Inc. (INSY), Arena ...
Top Biotechnology Stock Picking: INSYS Therapeutics, Inc. (INSY), Arena ...
Zergwatch - Aug 4, 2016
Arena Pharmaceuticals, Inc. (ARNA) recently recorded 6.13 percent change and currently at $1.73 is 33.08 percent away from its 52-week low and down -57.6 percent versus its peak.